Education
About Us
Working with TipRanks
Follow Us
Liquidia Technologies Inc (LQDA)
NASDAQ:LQDA
Earnings Data
Report Date
Mar 12, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.45Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Liquidia has experienced a strong launch and financial performance with YUTREPIA, achieving significant prescription uptake and positive cash flow. However, the ongoing net loss and litigation uncertainty present challenges that could impact future performance.Company Guidance
Successful Launch of YUTREPIA
Within the first 5 months of launch, YUTREPIA exceeded expectations with over 2,000 unique prescriptions, therapy initiated for over 1,500 patients, and over 600 healthcare practitioners prescribing it across the U.S. The referral-to-start ratio is around 85%.
Financial Performance
In the third quarter, Liquidia delivered $51.7 million in net product sales of YUTREPIA with relatively flat R&D and SG&A expenses. The company achieved positive adjusted EBITDA of $10.1 million, ahead of previous guidance.
Positive Cash Flow
September marked Liquidia's first month of positive net cash flow, adding $5 million in net cash and continuing to build momentum with additional gains in October.
Market Penetration
YUTREPIA is gaining traction with 3 out of 4 patients being new to treprostinil and 1 out of 4 transitioning from other prostacyclin therapies. The product is redefining expectations for inhaled delivery of treprostinil.
Strategic Growth Plans
Liquidia plans to reinvest in R&D to support sustained long-term growth and broaden YUTREPIA's clinical utility with niche studies and exploring new indications.
LQDA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LQDA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 12, 2025 | $21.20 | $24.10 | +13.68% |
May 08, 2025 | $15.53 | $15.35 | -1.16% |
Mar 19, 2025 | $14.74 | $14.92 | +1.22% |
Nov 13, 2024 | $10.63 | $10.27 | -3.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Liquidia Technologies Inc (LQDA) report earnings?
Liquidia Technologies Inc (LQDA) is schdueled to report earning on Mar 12, 2026, TBA (Confirmed).
What is Liquidia Technologies Inc (LQDA) earnings time?
Liquidia Technologies Inc (LQDA) earnings time is at Mar 12, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LQDA EPS forecast?
LQDA EPS forecast for the fiscal quarter 2025 (Q4) is -0.01.